Save your place

Sign in to WhoBought

Please try again later.

Vir Biotechnology, Inc. (VIR) institutional ownership

Market cap$695M SectorHealthcare
Funds holding · Q1 2026
249
reported VIR position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
179 buyers · 70 sellers

Vir Biotechnology, Inc. (VIR) price and institutional activity

Dates

Q1 2026

$0 bought by 179 investors
VanguardAdar1 Capital Management, LLC +177 more
$0 sold by 70 investors
Orbimed Advisors LLCSb Investment Advisers (uk) Ltd +68 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Vir Biotechnology, Inc. (VIR) institutional activity · 249

Investor Type Est. change Change Δ Own Date
Vanguard · Added
Change +3.0M Date Q1 2026
Vanguard Added· Q1 2026 +3.0M Q1 2026
Adar1 Capital Management, LLC · New
Change +2.7M Date Q1 2026
Adar1 Capital Management, LLC New· Q1 2026 +2.7M Q1 2026
Orbimed Advisors LLC · Exited
Change −2.4M Δ Own −100.0% Date Q1 2026
Orbimed Advisors LLC Exited· Q1 2026 −2.4M −100.0% Q1 2026
Sb Investment Advisers (uk) Ltd · Reduced
Change −2.2M Date Q1 2026
Sb Investment Advisers (uk) Ltd Reduced· Q1 2026 −2.2M Q1 2026
Soleus Capital Management, L.P. · New
Change +2.0M Date Q1 2026
Soleus Capital Management, L.P. New· Q1 2026 +2.0M Q1 2026
Point72 Asset Management, L.P. · Added
Change +1.8M Δ Own +897.5% Date Q1 2026
Point72 Asset Management, L.P. Added· Q1 2026 +1.8M +897.5% Q1 2026
Goldman Sachs Group Inc · Added
Change +1.7M Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +1.7M Q1 2026
BlackRock · Added
Change +1.7M Date Q1 2026
BlackRock Added· Q1 2026 +1.7M Q1 2026
Citadel Advisors LLC Added· Q1 2026 +1.6M +328.9% Q1 2026
Pictet Asset Management Holding SA · Added
Change +1.5M Date Q1 2026
Pictet Asset Management Holding SA Added· Q1 2026 +1.5M Q1 2026
Jacobs Levy Equity Management, Inc · New
Change +1.4M Date Q1 2026
Jacobs Levy Equity Management, Inc New· Q1 2026 +1.4M Q1 2026
Aberdeen Group PLC · Exited
Change −1.4M Δ Own −100.0% Date Q1 2026
Aberdeen Group PLC Exited· Q1 2026 −1.4M −100.0% Q1 2026
Balyasny Asset Management L.P. · Exited
Change −1.4M Δ Own −100.0% Date Q1 2026
Balyasny Asset Management L.P. Exited· Q1 2026 −1.4M −100.0% Q1 2026
Boxer Capital Management, LLC · Added
Change +1.2M Date Q1 2026
Boxer Capital Management, LLC Added· Q1 2026 +1.2M Q1 2026
Clearstead Advisors, LLC · New
Change +1.2M Date Q1 2026
Clearstead Advisors, LLC New· Q1 2026 +1.2M Q1 2026
Data through Q1 2026 · filed Jun 9, 2026
15 of 249

Famous investor activity in Vir Biotechnology, Inc. (VIR)

Vir Biotechnology, Inc. (VIR) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Coughlin Timothy · Director 4 operations 48K
Owned 16K Trade date Jun 9, 2026 Filed date Jun 10, 2026
Coughlin Timothy Director 4 operations 48K 16K Jun 9, 2026 Jun 10, 2026
Napolitano Janet · Director Sell −$30K
Price $9.45 Qty −3K Owned 21K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Napolitano Janet Director Sell $9.45 −3K −$30K 21K Jun 1, 2026 Jun 2, 2026
Sabatini Brent · Officer Sell −$4K
Price $9.45 Qty −379 Owned 62K Trade date Jun 1, 2026 Filed date Jun 2, 2026
Sabatini Brent Officer Sell $9.45 −379 −$4K 62K Jun 1, 2026 Jun 2, 2026
Sigal Charles Elliott · Director 2 operations 24K
Owned 16K Trade date May 27, 2026 Filed date May 28, 2026
Sigal Charles Elliott Director 2 operations 24K 16K May 27, 2026 May 28, 2026
Napolitano Janet · Director 2 operations 24K
Owned 16K Trade date May 27, 2026 Filed date May 28, 2026
Napolitano Janet Director 2 operations 24K 16K May 27, 2026 May 28, 2026
More Robert J. · Director 2 operations 24K
Owned 16K Trade date May 27, 2026 Filed date May 28, 2026
More Robert J. Director 2 operations 24K 16K May 27, 2026 May 28, 2026
Hatfield Jeffrey S. · Director 2 operations 24K
Owned 16K Trade date May 27, 2026 Filed date May 28, 2026
Hatfield Jeffrey S. Director 2 operations 24K 16K May 27, 2026 May 28, 2026
Farid Ramy · Director 2 operations 24K
Owned 16K Trade date May 27, 2026 Filed date May 28, 2026
Farid Ramy Director 2 operations 24K 16K May 27, 2026 May 28, 2026
Bischofberger Norbert W. · Director 2 operations 24K
Owned 16K Trade date May 27, 2026 Filed date May 28, 2026
Bischofberger Norbert W. Director 2 operations 24K 16K May 27, 2026 May 28, 2026
Sato Vicki L. · Director Sell −$221K
Price $10.05 Qty −22K Owned 1.1M Trade date May 1, 2026 Filed date May 4, 2026
Sato Vicki L. Director Sell $10.05 −22K −$221K 1.1M May 1, 2026 May 4, 2026
De Backer Marianne · Director 2 operations 0
Owned 287K Trade date Apr 29, 2026 Filed date Apr 30, 2026
De Backer Marianne Director 2 operations 0 287K Apr 29, 2026 Apr 30, 2026
11 of 11

Vir Biotechnology, Inc. (VIR) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Softbank Vision Fund (aiv M1) L.P. 20.3M
% of shares outstanding 15.2% Filing date Feb 14, 2023
Softbank Vision Fund (aiv M1) L.P. 20.3M 15.2% Feb 14, 2023
BlackRock Inc. 16.9M
% of shares outstanding 12.5% Filing date Jan 23, 2024
BlackRock Inc. 16.9M 12.5% Jan 23, 2024
Arch Venture Fund Ix, L.P. 12.9M
% of shares outstanding 9.7% Filing date Sep 13, 2022
Arch Venture Fund Ix, L.P. 12.9M 9.7% Sep 13, 2022
Vanguard Group Inc 12.3M
% of shares outstanding 9.1% Filing date Feb 13, 2024
Vanguard Group Inc 12.3M 9.1% Feb 13, 2024
Sb Investment Advisers (uk) Limited 10.9M
% of shares outstanding 6.5% Filing date May 15, 2026
Sb Investment Advisers (uk) Limited 10.9M 6.5% May 15, 2026
Glaxosmithkline PLC 8.6M
% of shares outstanding 6.5% Filing date Feb 10, 2022
Glaxosmithkline PLC 8.6M 6.5% Feb 10, 2022
Vanguard Portfolio Management 9.3M
% of shares outstanding 5.8% Filing date Apr 29, 2026
Vanguard Portfolio Management 9.3M 5.8% Apr 29, 2026
Scangos George A 6.3M
% of shares outstanding 4.8% Filing date Feb 14, 2022
Scangos George A 6.3M 4.8% Feb 14, 2022
8 of 10

Vir Biotechnology, Inc. (VIR) ownership FAQ

Who owns VIR?

249 reporting institutions disclosed VIR position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.